Company: NKLR
Filing Date: 2025-05-14
Form Type: S-4
Source: 0001213900-25-043376
Chunk: 296

Company: Terra Innovatum Global N.V.
Filing Date: 2025-05-14
Form: S-4
Chunk 296
---
 materially from those anticipated in these forward -looking statements as a result of various factors, including those set forth under “Risk Factors” or in other parts of this proxy statement / prospectus. Unless the context otherwise requires, references in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations of Terra” to “we”, “our” and “the Company” refer to the business and operations of Terra Innovatum, Srl. prior to the Business Combination and to Terra Innovatum, Srl. following the consummation of the Business Combination. Company Overview Terra Innovatum is a pioneering nuclear energy technology company developing the SOLO Micro -ModularNuclear Reactor, a breakthrough solution designed to address critical challenges in clean energy production. Our reactor represents a significant technological and engineering advancement, offering a compact, safe, and economically compelling alternative to traditional energy infrastructure. The SOLO reactor’s core innovation lies in its ability to generate 1 MWe of electricity baseload with a continuous operational cycle of up to 15 years, extendable to 45 years through strategic refuelling, with a fixed and competitive projected levelized cost of energy. Our strategic roadmap targets commercial deployment by 2028, with a clear focus on delivering a scalable, modular nuclear solution that can be deployed across diverse markets — from industrial and infrastructure to remote and off -gridapplications. Key differentiators include our gas -cooleddesign, multiple safety shutdown mechanisms, safeguard -by -design, small footprint, and the ability to use commercially available Low Enriched Uranium (“LEU”), which significantly reduces regulatory and technological barriers typical in nuclear energy development. We have made substantial progress in de -riskingits First -of - a-Kind(“FOAK”) reactor, including initiating regulatory engagement with the U.S. Nuclear Regulatory Commission (“NRC”), and establishing a robust supply chain strategy. We have completed our reactor design, validated key technological components, and are advancing through critical regulatory milestones to achieve our 2028 FOAK reactor completion target. Recent Developments During the year ended December 31, 2024, we entered into an interest -freeloan agreement with our shareholders. The total loan amount of $216,212 is to be provided in cash installments by January 15, 2025. The loan is scheduled to mature on December 31, 2040, with automatic annual extensions permitted until December 31, 2045, unless payment is requested by the shareholders. On March 21, 2025